Ko-Med Centra Kliniczne Sp. z o.o.

At Ko-Med Centra Kliniczne Sp. z o.o. in Zamosc, a large share of studies focuses on cardiovascular diseases and nutritional and metabolic diseases, especially conditions such as atherosclerotic cardiovascular disease, heart failure, hypertension, atrial fibrillation, type 2 diabetes, obesity, and hypertriglyceridemia. These trials are mainly designed to test new treatments and improve prevention of major heart and vascular events, while also helping better control blood sugar, weight, and lipid levels.

• Atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation studies aimed at reducing stroke and other serious cardiovascular events
• Type 2 diabetes, obesity, and hypertriglyceridemia research focused on improving metabolic control and weight management
• Hypertension trials evaluating better blood pressure control in people with difficult-to-treat disease

The site’s cardiology department is especially active in research that links cardiovascular risk with metabolic disorders, reflecting a strong interest in both prevention and long-term disease management.

Another major research area covers immune system diseases, hemic and lymphatic diseases, and musculoskeletal diseases. The trials include people with systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and ulcerative colitis, with the goal of finding better ways to reduce inflammation, improve symptoms, and support longer-term disease control.

• Systemic lupus erythematosus studies evaluating new options to lower disease activity
• Rheumatoid arthritis and psoriatic arthritis research aimed at improving joint and axial symptom relief
• Ulcerative colitis trials focused on maintaining control of chronic intestinal inflammation

This part of the research portfolio highlights ongoing efforts to refine treatment for complex autoimmune conditions that can affect multiple organs and daily functioning.

The site also conducts notable studies in skin and connective tissue diseases and immune-mediated allergic conditions. Research includes atopic dermatitis, psoriasis, acne vulgaris, and chronic spontaneous urticaria, with trials designed to test new therapies, compare treatment approaches, and assess longer-term safety in people with persistent skin symptoms.

• Atopic dermatitis studies exploring improved symptom control and durability of response
• Psoriasis and psoriatic arthritis research examining better management of inflammatory skin and joint disease
• Acne vulgaris and urticaria trials focused on symptom relief and treatment tolerability

These studies reflect a broad effort to improve both visible symptoms and quality of life for patients living with chronic dermatologic disease.

A further area of research includes respiratory tract diseases, virus diseases, and bacterial infections. Trials at the site involve chronic rhinosinusitis, influenza, respiratory syncytial virus, human metapneumovirus, and group B streptococcus, along with a study on recurrent vulvovaginal candidiasis. The main purpose is to evaluate vaccines and new therapies that may prevent infection or improve symptom control.

• Chronic rhinosinusitis studies looking for better relief of congestion and related symptoms
• Influenza, RSV, and hMPV vaccine research aimed at prevention in older adults
• Group B streptococcus and candida studies focused on infection prevention and immune response

This portfolio shows a strong preventive medicine focus, especially for infections that can have a greater impact in older or vulnerable populations.

The remaining studies span nervous system diseases and digestive system diseases, including migraine, chronic low back pain, non-alcoholic steatohepatitis, and digestive inflammation such as ulcerative colitis. These trials are generally aimed at improving symptom relief, testing new treatment options, and better understanding disease progression in chronic conditions that can be difficult to manage.

• Migraine research focused on prevention and reduction of attack frequency
• Chronic low back pain studies assessing new approaches for pain reduction
• Non-alcoholic steatohepatitis trials examining whether new therapies can improve liver health and slow disease progression

Together, these studies add depth to the site’s clinical research profile by addressing both common and highly burdensome long-term conditions.